1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global GFAP Antibody Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Polyclonal 1.2.3 Monoclonal 1.3 Market by Application 1.3.1 Global GFAP Antibody Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Immunofluorescence 1.3.3 Western Blot 1.3.4 Immunohistochemistry Frozen 1.3.5 Immunohistochemistry Paraffin 1.3.6 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global GFAP Antibody Market Perspective (2017-2028) 2.2 GFAP Antibody Growth Trends by Region 2.2.1 GFAP Antibody Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 GFAP Antibody Historic Market Size by Region (2017-2022) 2.2.3 GFAP Antibody Forecasted Market Size by Region (2023-2028) 2.3 GFAP Antibody Market Dynamics 2.3.1 GFAP Antibody Industry Trends 2.3.2 GFAP Antibody Market Drivers 2.3.3 GFAP Antibody Market Challenges 2.3.4 GFAP Antibody Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top GFAP Antibody Players by Revenue 3.1.1 Global Top GFAP Antibody Players by Revenue (2017-2022) 3.1.2 Global GFAP Antibody Revenue Market Share by Players (2017-2022) 3.2 Global GFAP Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by GFAP Antibody Revenue 3.4 Global GFAP Antibody Market Concentration Ratio 3.4.1 Global GFAP Antibody Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by GFAP Antibody Revenue in 2021 3.5 GFAP Antibody Key Players Head office and Area Served 3.6 Key Players GFAP Antibody Product Solution and Service 3.7 Date of Enter into GFAP Antibody Market 3.8 Mergers & Acquisitions, Expansion Plans 4 GFAP Antibody Breakdown Data by Type 4.1 Global GFAP Antibody Historic Market Size by Type (2017-2022) 4.2 Global GFAP Antibody Forecasted Market Size by Type (2023-2028) 5 GFAP Antibody Breakdown Data by Application 5.1 Global GFAP Antibody Historic Market Size by Application (2017-2022) 5.2 Global GFAP Antibody Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America GFAP Antibody Market Size (2017-2028) 6.2 North America GFAP Antibody Market Size by Country (2017-2022) 6.3 North America GFAP Antibody Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe GFAP Antibody Market Size (2017-2028) 7.2 Europe GFAP Antibody Market Size by Country (2017-2022) 7.3 Europe GFAP Antibody Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific GFAP Antibody Market Size (2017-2028) 8.2 Asia-Pacific GFAP Antibody Market Size by Country (2017-2022) 8.3 Asia-Pacific GFAP Antibody Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America GFAP Antibody Market Size (2017-2028) 9.2 Latin America GFAP Antibody Market Size by Country (2017-2022) 9.3 Latin America GFAP Antibody Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa GFAP Antibody Market Size (2017-2028) 10.2 Middle East & Africa GFAP Antibody Market Size by Country (2017-2022) 10.3 Middle East & Africa GFAP Antibody Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Aviva Systems Biology 11.1.1 Aviva Systems Biology Company Detail 11.1.2 Aviva Systems Biology Business Overview 11.1.3 Aviva Systems Biology GFAP Antibody Introduction 11.1.4 Aviva Systems Biology Revenue in GFAP Antibody Business (2017-2022) 11.1.5 Aviva Systems Biology Recent Development 11.2 Merck 11.2.1 Merck Company Detail 11.2.2 Merck Business Overview 11.2.3 Merck GFAP Antibody Introduction 11.2.4 Merck Revenue in GFAP Antibody Business (2017-2022) 11.2.5 Merck Recent Development 11.3 FineTest 11.3.1 FineTest Company Detail 11.3.2 FineTest Business Overview 11.3.3 FineTest GFAP Antibody Introduction 11.3.4 FineTest Revenue in GFAP Antibody Business (2017-2022) 11.3.5 FineTest Recent Development 11.4 Santa Cruz Biotechnology 11.4.1 Santa Cruz Biotechnology Company Detail 11.4.2 Santa Cruz Biotechnology Business Overview 11.4.3 Santa Cruz Biotechnology GFAP Antibody Introduction 11.4.4 Santa Cruz Biotechnology Revenue in GFAP Antibody Business (2017-2022) 11.4.5 Santa Cruz Biotechnology Recent Development 11.5 Miltenyi Biotec 11.5.1 Miltenyi Biotec Company Detail 11.5.2 Miltenyi Biotec Business Overview 11.5.3 Miltenyi Biotec GFAP Antibody Introduction 11.5.4 Miltenyi Biotec Revenue in GFAP Antibody Business (2017-2022) 11.5.5 Miltenyi Biotec Recent Development 11.6 Sino Biological 11.6.1 Sino Biological Company Detail 11.6.2 Sino Biological Business Overview 11.6.3 Sino Biological GFAP Antibody Introduction 11.6.4 Sino Biological Revenue in GFAP Antibody Business (2017-2022) 11.6.5 Sino Biological Recent Development 11.7 Enzo Life Sciences 11.7.1 Enzo Life Sciences Company Detail 11.7.2 Enzo Life Sciences Business Overview 11.7.3 Enzo Life Sciences GFAP Antibody Introduction 11.7.4 Enzo Life Sciences Revenue in GFAP Antibody Business (2017-2022) 11.7.5 Enzo Life Sciences Recent Development 11.8 Proteintech 11.8.1 Proteintech Company Detail 11.8.2 Proteintech Business Overview 11.8.3 Proteintech GFAP Antibody Introduction 11.8.4 Proteintech Revenue in GFAP Antibody Business (2017-2022) 11.8.5 Proteintech Recent Development 11.9 Atlas Antibodies 11.9.1 Atlas Antibodies Company Detail 11.9.2 Atlas Antibodies Business Overview 11.9.3 Atlas Antibodies GFAP Antibody Introduction 11.9.4 Atlas Antibodies Revenue in GFAP Antibody Business (2017-2022) 11.9.5 Atlas Antibodies Recent Development 11.10 GeneTex 11.10.1 GeneTex Company Detail 11.10.2 GeneTex Business Overview 11.10.3 GeneTex GFAP Antibody Introduction 11.10.4 GeneTex Revenue in GFAP Antibody Business (2017-2022) 11.10.5 GeneTex Recent Development 11.11 Synaptic Systems 11.11.1 Synaptic Systems Company Detail 11.11.2 Synaptic Systems Business Overview 11.11.3 Synaptic Systems GFAP Antibody Introduction 11.11.4 Synaptic Systems Revenue in GFAP Antibody Business (2017-2022) 11.11.5 Synaptic Systems Recent Development 11.12 Hytest 11.12.1 Hytest Company Detail 11.12.2 Hytest Business Overview 11.12.3 Hytest GFAP Antibody Introduction 11.12.4 Hytest Revenue in GFAP Antibody Business (2017-2022) 11.12.5 Hytest Recent Development 11.13 ProSci 11.13.1 ProSci Company Detail 11.13.2 ProSci Business Overview 11.13.3 ProSci GFAP Antibody Introduction 11.13.4 ProSci Revenue in GFAP Antibody Business (2017-2022) 11.13.5 ProSci Recent Development 11.14 EnCor Biotechnology 11.14.1 EnCor Biotechnology Company Detail 11.14.2 EnCor Biotechnology Business Overview 11.14.3 EnCor Biotechnology GFAP Antibody Introduction 11.14.4 EnCor Biotechnology Revenue in GFAP Antibody Business (2017-2022) 11.14.5 EnCor Biotechnology Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global GFAP Antibody Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Polyclonal Table 3. Key Players of Monoclonal Table 4. Global GFAP Antibody Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 5. Global GFAP Antibody Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global GFAP Antibody Market Size by Region (2017-2022) & (US$ Million) Table 7. Global GFAP Antibody Market Share by Region (2017-2022) Table 8. Global GFAP Antibody Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global GFAP Antibody Market Share by Region (2023-2028) Table 10. GFAP Antibody Market Trends Table 11. GFAP Antibody Market Drivers Table 12. GFAP Antibody Market Challenges Table 13. GFAP Antibody Market Restraints Table 14. Global GFAP Antibody Revenue by Players (2017-2022) & (US$ Million) Table 15. Global GFAP Antibody Market Share by Players (2017-2022) Table 16. Global Top GFAP Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GFAP Antibody as of 2021) Table 17. Ranking of Global Top GFAP Antibody Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by GFAP Antibody Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players GFAP Antibody Product Solution and Service Table 21. Date of Enter into GFAP Antibody Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global GFAP Antibody Market Size by Type (2017-2022) & (US$ Million) Table 24. Global GFAP Antibody Revenue Market Share by Type (2017-2022) Table 25. Global GFAP Antibody Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global GFAP Antibody Revenue Market Share by Type (2023-2028) Table 27. Global GFAP Antibody Market Size by Application (2017-2022) & (US$ Million) Table 28. Global GFAP Antibody Revenue Market Share by Application (2017-2022) Table 29. Global GFAP Antibody Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global GFAP Antibody Revenue Market Share by Application (2023-2028) Table 31. North America GFAP Antibody Market Size by Country (2017-2022) & (US$ Million) Table 32. North America GFAP Antibody Market Size by Country (2023-2028) & (US$ Million) Table 33. Europe GFAP Antibody Market Size by Country (2017-2022) & (US$ Million) Table 34. Europe GFAP Antibody Market Size by Country (2023-2028) & (US$ Million) Table 35. Asia-Pacific GFAP Antibody Market Size by Region (2017-2022) & (US$ Million) Table 36. Asia-Pacific GFAP Antibody Market Size by Region (2023-2028) & (US$ Million) Table 37. Latin America GFAP Antibody Market Size by Country (2017-2022) & (US$ Million) Table 38. Latin America GFAP Antibody Market Size by Country (2023-2028) & (US$ Million) Table 39. Middle East & Africa GFAP Antibody Market Size by Country (2017-2022) & (US$ Million) Table 40. Middle East & Africa GFAP Antibody Market Size by Country (2023-2028) & (US$ Million) Table 41. Aviva Systems Biology Company Detail Table 42. Aviva Systems Biology Business Overview Table 43. Aviva Systems Biology GFAP Antibody Product Table 44. Aviva Systems Biology Revenue in GFAP Antibody Business (2017-2022) & (US$ Million) Table 45. Aviva Systems Biology Recent Development Table 46. Merck Company Detail Table 47. Merck Business Overview Table 48. Merck GFAP Antibody Product Table 49. Merck Revenue in GFAP Antibody Business (2017-2022) & (US$ Million) Table 50. Merck Recent Development Table 51. FineTest Company Detail Table 52. FineTest Business Overview Table 53. FineTest GFAP Antibody Product Table 54. FineTest Revenue in GFAP Antibody Business (2017-2022) & (US$ Million) Table 55. FineTest Recent Development Table 56. Santa Cruz Biotechnology Company Detail Table 57. Santa Cruz Biotechnology Business Overview Table 58. Santa Cruz Biotechnology GFAP Antibody Product Table 59. Santa Cruz Biotechnology Revenue in GFAP Antibody Business (2017-2022) & (US$ Million) Table 60. Santa Cruz Biotechnology Recent Development Table 61. Miltenyi Biotec Company Detail Table 62. Miltenyi Biotec Business Overview Table 63. Miltenyi Biotec GFAP Antibody Product Table 64. Miltenyi Biotec Revenue in GFAP Antibody Business (2017-2022) & (US$ Million) Table 65. Miltenyi Biotec Recent Development Table 66. Sino Biological Company Detail Table 67. Sino Biological Business Overview Table 68. Sino Biological GFAP Antibody Product Table 69. Sino Biological Revenue in GFAP Antibody Business (2017-2022) & (US$ Million) Table 70. Sino Biological Recent Development Table 71. Enzo Life Sciences Company Detail Table 72. Enzo Life Sciences Business Overview Table 73. Enzo Life Sciences GFAP Antibody Product Table 74. Enzo Life Sciences Revenue in GFAP Antibody Business (2017-2022) & (US$ Million) Table 75. Enzo Life Sciences Recent Development Table 76. Proteintech Company Detail Table 77. Proteintech Business Overview Table 78. Proteintech GFAP Antibody Product Table 79. Proteintech Revenue in GFAP Antibody Business (2017-2022) & (US$ Million) Table 80. Proteintech Recent Development Table 81. Atlas Antibodies Company Detail Table 82. Atlas Antibodies Business Overview Table 83. Atlas Antibodies GFAP Antibody Product Table 84. Atlas Antibodies Revenue in GFAP Antibody Business (2017-2022) & (US$ Million) Table 85. Atlas Antibodies Recent Development Table 86. GeneTex Company Detail Table 87. GeneTex Business Overview Table 88. GeneTex GFAP Antibody Product Table 89. GeneTex Revenue in GFAP Antibody Business (2017-2022) & (US$ Million) Table 90. GeneTex Recent Development Table 91. Synaptic Systems Company Detail Table 92. Synaptic Systems Business Overview Table 93. Synaptic Systems GFAP AntibodyProduct Table 94. Synaptic Systems Revenue in GFAP Antibody Business (2017-2022) & (US$ Million) Table 95. Synaptic Systems Recent Development Table 96. Hytest Company Detail Table 97. Hytest Business Overview Table 98. Hytest GFAP AntibodyProduct Table 99. Hytest Revenue in GFAP Antibody Business (2017-2022) & (US$ Million) Table 100. Hytest Recent Development Table 101. ProSci Company Detail Table 102. ProSci Business Overview Table 103. ProSci GFAP AntibodyProduct Table 104. ProSci Revenue in GFAP Antibody Business (2017-2022) & (US$ Million) Table 105. ProSci Recent Development Table 106. EnCor Biotechnology Company Detail Table 107. EnCor Biotechnology Business Overview Table 108. EnCor Biotechnology GFAP AntibodyProduct Table 109. EnCor Biotechnology Revenue in GFAP Antibody Business (2017-2022) & (US$ Million) Table 110. EnCor Biotechnology Recent Development Table 111. Research Programs/Design for This Report Table 112. Key Data Information from Secondary Sources Table 113. Key Data Information from Primary Sources List of Figures Figure 1. Global GFAP Antibody Market Share by Type: 2021 VS 2028 Figure 2. Polyclonal Features Figure 3. Monoclonal Features Figure 4. Global GFAP Antibody Market Share by Application in 2021 & 2028 Figure 5. Immunofluorescence Case Studies Figure 6. Western Blot Case Studies Figure 7. Immunohistochemistry Frozen Case Studies Figure 8. Immunohistochemistry Paraffin Case Studies Figure 9. Others Case Studies Figure 10. GFAP Antibody Report Years Considered Figure 11. Global GFAP Antibody Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global GFAP Antibody Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global GFAP Antibody Market Share by Region: 2021 VS 2028 Figure 14. Global GFAP Antibody Market Share by Players in 2021 Figure 15. Global Top GFAP Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GFAP Antibody as of 2021) Figure 16. The Top 10 and 5 Players Market Share by GFAP Antibody Revenue in 2021 Figure 17. North America GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. North America GFAP Antibody Market Share by Country (2017-2028) Figure 19. United States GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Canada GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe GFAP Antibody Market Share by Country (2017-2028) Figure 23. Germany GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. France GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. U.K. GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Italy GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Russia GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Nordic Countries GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific GFAP Antibody Market Share by Region (2017-2028) Figure 31. China GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Japan GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. South Korea GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Southeast Asia GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. India GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Australia GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America GFAP Antibody Market Share by Country (2017-2028) Figure 39. Mexico GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Brazil GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa GFAP Antibody Market Share by Country (2017-2028) Figure 43. Turkey GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Saudi Arabia GFAP Antibody Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Aviva Systems Biology Revenue Growth Rate in GFAP Antibody Business (2017-2022) Figure 46. Merck Revenue Growth Rate in GFAP Antibody Business (2017-2022) Figure 47. FineTest Revenue Growth Rate in GFAP Antibody Business (2017-2022) Figure 48. Santa Cruz Biotechnology Revenue Growth Rate in GFAP Antibody Business (2017-2022) Figure 49. Miltenyi Biotec Revenue Growth Rate in GFAP Antibody Business (2017-2022) Figure 50. Sino Biological Revenue Growth Rate in GFAP Antibody Business (2017-2022) Figure 51. Enzo Life Sciences Revenue Growth Rate in GFAP Antibody Business (2017-2022) Figure 52. Proteintech Revenue Growth Rate in GFAP Antibody Business (2017-2022) Figure 53. Atlas Antibodies Revenue Growth Rate in GFAP Antibody Business (2017-2022) Figure 54. GeneTex Revenue Growth Rate in GFAP Antibody Business (2017-2022) Figure 55. Synaptic Systems Revenue Growth Rate in GFAP Antibody Business (2017-2022) Figure 56. Hytest Revenue Growth Rate in GFAP Antibody Business (2017-2022) Figure 57. ProSci Revenue Growth Rate in GFAP Antibody Business (2017-2022) Figure 58. EnCor Biotechnology Revenue Growth Rate in GFAP Antibody Business (2017-2022) Figure 59. Bottom-up and Top-down Approaches for This Report Figure 60. Data Triangulation Figure 61. Key Executives Interviewed

Aviva Systems Biology Merck FineTest Santa Cruz Biotechnology Miltenyi Biotec Sino Biological Enzo Life Sciences Proteintech Atlas Antibodies GeneTex Synaptic Systems Hytest ProSci EnCor Biotechnology